NJ State Employees Deferred Compensation Plan’s Nektar Therapeutics NKTR Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-533	Closed	-$285K	–	548
2019 Q2	$285K	Sell	533 -67	-11%	-$33.6K	0.05%	440
2019 Q1	$302K	Hold	600	–	–	0.05%	430
2018 Q4	$296K	Buy	+600	New	+$362K	0.06%	385
2018 Q3	–	Sell	-400	Closed	-$293K	–	522
2018 Q2	$293K	Sell	400 -133	-25%	-$153K	0.05%	427
2018 Q1	$850K	Buy	+533	New	+$687K	0.15%	180
2017 Q4	–	Sell	-1,333	Closed	-$480K	–	481
2017 Q3	$480K	Sell	1,333 -667	-33%	-$209K	0.09%	323
2017 Q2	$587K	Hold	2,000	–	–	0.11%	255
2017 Q1	$704K	Hold	2,000	–	–	0.13%	234
2016 Q4	$368K	Hold	2,000	–	–	0.07%	293
2016 Q3	$515K	Hold	2,000	–	–	0.11%	268
2016 Q2	$427K	Hold	2,000	–	–	0.09%	283
2016 Q1	$460K	Hold	2,000	–	–	0.1%	279
2015 Q4	$506K	Hold	2,000	–	–	0.1%	274
2015 Q3	$329K	Hold	2,000	–	–	0.07%	312
2015 Q2	$375K	Hold	2,000	–	–	0.07%	306
2015 Q1	$330K	Hold	2,000	–	–	0.06%	320
2014 Q4	$465K	Hold	2,000	–	–	0.09%	295
2014 Q3	$362K	Hold	2,000	–	–	0.07%	315
2014 Q2	$385K	Hold	2,000	–	–	0.08%	320
2014 Q1	$364K	Hold	2,000	–	–	0.07%	322
2013 Q4	$341K	Hold	2,000	–	–	0.07%	329
2013 Q3	$313K	Hold	2,000	–	–	0.07%	337
2013 Q2	$347K	Buy	+2,000	New	+$307K	0.08%	327

Other funds holding NKTR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's NKTR Position: Q3 2019 in Review

NJ State Employees Deferred Compensation Plan sold out of Nektar Therapeutics (NKTR) in Q3 2019, closing a stake of 533 shares — an estimated $285K sold.

NJ State Employees Deferred Compensation Plan first reported a position in NKTR in Q2 2013 and held it in 23 quarters. The position peaked at $850K in Q1 2018. 287 funds tracked by Wall St. Rank hold NKTR as of Q3 2019.

NJ State Employees Deferred Compensation Plan reported no remaining Nektar Therapeutics position as of Q3 2019 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 533 Nektar Therapeutics shares in Q3 2019, an estimated $285K.
NJ State Employees Deferred Compensation Plan first reported a position in Nektar Therapeutics in Q2 2013 and held it in 23 quarters.
NJ State Employees Deferred Compensation Plan's Nektar Therapeutics position peaked at $850K in Q1 2018.
287 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2019.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q3 2019, filed 18 Oct 2019.